GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Symbion Health Ltd (ASX:SY1) » Definitions » Research & Development

Symbion Health (ASX:SY1) Research & Development : A$0.00 Mil (TTM As of Jun. 2007)


View and export this data going back to . Start your Free Trial

What is Symbion Health Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Symbion Health's Research & Development for the six months ended in Jun. 2007 was A$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2007 was A$0.00 Mil.

Symbion Health Research & Development Historical Data

The historical data trend for Symbion Health's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Symbion Health Research & Development Chart

Symbion Health Annual Data
Trend Jun98 Jun99 Jun00 Jun01 Jun02 Jun03 Jun04 Jun05 Jun06 Jun07
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 26.61 28.70 - -

Symbion Health Semi-Annual Data
Jun95 Jun96 Jun97 Jun98 Jun99 Jun00 Jun01 Jun02 Jun03 Jun04 Jun05 Jun06 Jun07
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 26.61 28.70 - -

Symbion Health Research & Development Calculation

This is the expense the company spent on research and development.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Research & Development for the trailing twelve months (TTM) ended in Jun. 2007 was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Symbion Health  (ASX:SY1) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Symbion Health Research & Development Related Terms

Thank you for viewing the detailed overview of Symbion Health's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Symbion Health (ASX:SY1) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Symbion Health Ltd (ASX:SY1) » Definitions » Research & Development
Comparable Companies
ASX:ONT
Traded in Other Exchanges
N/A
Address
Website
http://www.symbionhealth.com
Symbion Group Limited (SYB, formerly Mayne Group Limited) is a healthcare-focused company comprised of 5 divisions: Pathology; Medical Centres; Imaging; Pharmacy Services; and Symbion Consumer.

Symbion Health (ASX:SY1) Headlines

No Headlines